ProCE Banner Activity

Should We Treat Biochemical Relapse in Multiple Myeloma?

Clinical Thought

Read my thoughts on treating patients with multiple myeloma who experience biochemical relapse.

This educational activity is intended for clinicians practicing medicine outside of the United States.

Released: September 22, 2020

Expiration: September 21, 2021

No longer available for credit.

Share

Faculty

Jesus San-Miguel

Jesus San-Miguel, MD, PhD

Director of Clinical and Translational Medicine
Clinica Universidad de Navarra
Universidad de Navarra
Pamplona, Spain

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

GlaxoSmithKline

Faculty Disclosure

Primary Author

Jesus San-Miguel, MD, PhD

Director of Clinical and Translational Medicine
Clinica Universidad de Navarra
Universidad de Navarra
Pamplona, Spain

Jesús F. San-Miguel, MD, PhD, has disclosed that he has received consulting fees from Amgen, Bristol-Myers Squibb, Celgene, Janssen, Novartis, Sanofi, and Takeda.